This document discusses the evaluation and management of acute coronary syndrome (ACS) and ST-segment elevation myocardial infarction (STEMI). It begins by outlining the epidemiology of cardiovascular disease and ACS. It then reviews the history, physical exam findings, EKG findings, biomarkers, and risk scores used to evaluate patients with potential ACS. Various treatment options for STEMI are discussed including thrombolytics, percutaneous coronary intervention (PCI), anticoagulants, antiplatelets, and beta blockers. Complications of STEMI and strategies to reduce door-to-balloon times for PCI are also summarized.